|
Journal of Lipid Research, Vol. 41, 814-823, May 2000
Copyright © 2000 by Lipid Research, Inc.
Involvement of the peroxisome proliferator-activated receptor in regulating long-chain acyl-CoA thioesterases
Mary C. Hunta,
Per J. G. Lindquist1,a,
Jeffrey M. Petersb,
Frank J. Gonzalezb,
Ulf Diczfalusya, and
Stefan E. H. Alexsona
a Department of Medical Laboratory Sciences and Technology, Division of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, S-141 86 Huddinge, Sweden
b Laboratory of Metabolism, National Institutes of Health, Bethesda, MD 20892
Correspondence to:
Stefan E. H. Alexson
 |
ABSTRACT |
|---|
Long-chain acyl-CoA thioesterases catalyze the hydrolysis of acyl-CoAs to the corresponding free fatty acid and CoA. We recently cloned four members of a novel multi-gene family of peroxisome proliferator-induced genes encoding cytosolic (CTE-I), mitochondrial (MTE-I), and peroxisomal (PTE-Ia and PTE-Ib) acyl-CoA thioesterases (Hunt et al. 1999. J. Biol. Chem. 274: 3431734326). As the peroxisome proliferator-activated receptor alpha (PPAR ) plays a central role in regulating genes involved in lipid metabolism, we examined the involvement of this receptor in regulation of the thioesterases, particularly CTE-I and MTE-I. Northern blot analysis shows that the induction of these thioesterases by clofibrate is mediated through a strictly PPAR -dependent mechanism. All four acyl-CoA thioesterases are induced at mRNA level by fasting and using PPAR -null mice, it is evident that the increase in CTE-I due to fasting is mainly independent of the PPAR in liver and heart. The CTE-I gene responds rapidly to fasting, with induction of mRNA and protein evident after 6 h. This fasting effect is rapidly reversible, with CTE-I mRNA returning almost to control levels after 3 h refeeding, and being further repressed to 20% of control after 9 h refeeding. Although CTE-I mRNA shows a low basal expression in liver, it can be suppressed 90% by feeding a fat-free diet.
These data demonstrate that the nutritional regulation of the thioesterases involves the PPAR and other signaling pathways responsible for activation and repression. Putative physiological functions for the acyl-CoA thioesterases are discussed.Hunt, M. C., P. J. G. Lindquist, J. M. Peters, F. J. Gonzalez, U. Diczfalusy, and S. E. H. Alexson. Involvement of the peroxisome proliferator-activated receptor in regulating long-chain acyl-CoA thioesterases. J. Lipid Res. 2000. 41: 814;823.
Supplementary key words:
acyl-CoA thioesterases, acyl-CoA, fasting, peroxisome proliferator-activated receptor, lipid metabolism, fat free diet, clofibrate
 |
INTRODUCTION |
|---|
Acyl-CoAs are important sources of metabolic energy and play roles in degradation and synthesis of fatty acids and their incorporation into complex lipids (for review, see ref. (1)). It is proposed that acyl-CoA esters are key regulators of fatty acid synthesis, and long-chain acyl-CoA esters also affect numerous cellular systems and functions such as regulation of ion channels, ion pumps, and translocators, together with membrane fusion and protein acylation (for review, see ref. (2)). Recently, acyl-CoAs and non-esterified fatty acids have also been implicated in other cellular processes, such as gene regulation, by acting as ligands for the hepatic nuclear factor 4 alpha (HNF-4 ) (3) and the peroxisome proliferator-activated receptor alpha (PPAR ) (4) (5), respectively. As long-chain acyl-CoA thioesterases (EC 3.1.2.2) belong to a family of enzymes that catalyze the hydrolysis of acyl-CoAs to free fatty acids and CoA, they can therefore be considered important mediators in many of the above cellular processes by regulating intracellular levels of non-esterified fatty acids and acyl-CoAs.
Long-chain acyl-CoA thioesterases are ubiquitously expressed in different organisms and cell types and show activity in several subcellular compartments, although their physiological functions remain unknown. The acyl-CoA thioesterase activity is strongly induced in rat and mouse liver by treatment with peroxisome proliferators. This induction occurs mainly in cytosol and mitochondria (6) (7) (8), and to a much lesser extent in peroxisomes (9) (10). The induced activity is due to two families of thioesterases of approximately 40 and 110;150 kDa, which are expressed in cytosol, mitochondria, and peroxisomes and which are only weakly expressed in liver under normal conditions (8). The low molecular mass enzymes are named CTE-I and MTE-I (cytosolic and mitochondrial acyl-CoA thioesterase, respectively) and the high molecular mass enzymes are named CTE-II and MTE-II (cytosolic and mitochondrial, respectively). Antibodies raised against MTE-I have been shown to cross-react with CTE-I and with peroxisomal acyl-CoA thioesterases (8) (11). This cross-reactivity suggested the existence of a structurally related family of peroxisome proliferator-inducible acyl-CoA thioesterases with multiple subcellular localizations. The cDNAs corresponding to both CTE-I and MTE-I from rat and CTE-I from mouse were recently cloned (12) (13) (14). The genes encoding mouse CTE-I, MTE-I, and two peroxisomal thioesterases, PTE-Ia and PTE-Ib, have also recently been cloned (15) and show a high degree of sequence similarity.
Previous studies showed that both CTE-I and MTE-I were inducible at mRNA level by treatment with the peroxisome proliferator clofibrate or by fasting (13). Peroxisome proliferators are a structurally diverse group of compounds that mediate their effects via the nuclear hormone receptor peroxisome proliferator-activated receptor alpha (PPAR ). The PPAR regulates the expression of several genes involved in fatty acid oxidation by binding as a heterodimeric complex with the retinoid X receptor (RXR) to a peroxisome proliferator response element (PPRE) located in the promoter region of the target gene, such as acyl-CoA oxidase (ACOX) (16), the enoyl-CoA hydratase/3-hydroxyacyl-CoA bifunctional enzyme (BIEN) (17), and P450 4A1 (CYP4A1 (18)). These PPREs are an almost perfect direct repeat of the sequence AGGTCA, spaced by one nucleotide (DR1 element). The important role of the PPAR in transcriptional regulation of genes involved in fatty acid oxidation was demonstrated by targeted disruption of the gene (19) (20). The PPAR -null mice showed lack of peroxisome proliferation, no hepatomegaly and lack of induction of peroxisome proliferator-regulated genes in response to treatment with peroxisome proliferators. The PPAR evidently plays a critical role in the adaptive response to fasting in mice (21) (22) (23), as the induction of several genes involved in lipid catabolism is abolished in the PPAR -null mice. Fatty acids can activate the PPAR and may be the natural ligands for PPARs in vivo, such as oleic, linoleic, linolenic, and arachidonic acid (4) (5) (24). Therefore, under conditions of increased levels of free fatty acids such as those associated with fasting, increased expression of PPAR -regulated genes is expected.
Although the long-chain acyl-CoA thioesterases are a family of highly regulated genes, the physiological roles of these enzymes have not yet been elucidated. It has been speculated that they may be involved in lipid metabolism by modulation of cellular concentrations of acyl-CoAs and fatty acids. The current study was undertaken to examine the involvement of the PPAR in the physiological regulation of these enzymes with the idea of elucidating their roles in lipid metabolism.
 |
MATERIALS AND METHODS |
|---|
Animals and treatments
Adult male C57 BL/6 mice, obtained from B & K, Sollentuna, Sweden, were used as indicated throughout this study. Ten- to 12-week-old wild-type or PPAR -null male mice on a pure Sv/129 genetic background (derived from the original colony of mixed background mice) (19) were housed in a temperature- and light-controlled environment. In fasting experiments, mice were maintained on a normal chow diet (Lactamin R36, Vadstena, Sweden) prior to the start of the experiment and then transferred to new cages and fasted for the time-points indicated in the figure legends. In some cases, after 24 h of fasting, the animals were refed a normal chow diet for various lengths of time before killing. Treatment with a fat-free diet (containing 64% carbohydrate, 17.6% protein, 4.2% ash, 4% fibre, and 19% water, AnalyCen, Linköping, Sweden) or a 0.5% clofibrate-containing diet (Atromidin, Zeneca Ltd, Cheshire, United Kingdom) was for up to 1 week. Diurnal variation was investigated with mice maintained on a normal chow diet and killed at the time-points as indicated. The dark periods were between 18.00 and 06.00 h. All mice had access to water ad libitum and experiments were commenced at 9.00 AM unless otherwise stated. Animals were killed by CO2 asphyxiation followed by cervical dislocation, and weighed immediately. Tissues were then excised, weighed, and frozen in liquid nitrogen. Tissue samples were stored at -70°C for preparation of total RNA.
Northern blot analysis
Total RNA was isolated from mouse tissue samples using either QuickPrepR Total RNA Extraction Kit (Pharmacia Biotech, Uppsala, Sweden) or Ultraspec RNA Kit (Biotecx Laboratories Inc., Houston, TX). Total RNA (either 10 or 20 µg as outlined in figure legends) was denatured in formaldehyde/formamide and electrophoresed on 1% formaldehyde-containing agarose gels with ethidium bromide. The RNA was transferred to Hybond-N nylon membranes (Amersham Pharmacia Biotech) by capillary action. A cDNA probe was prepared corresponding to the full length cDNA for CTE-I as described (13). An MTE-I specific probe of 120 bp was prepared by PCR amplification of the mitochondrial leader peptide of MTE-I. Probes for mouse PTE-Ia and PTE-Ib were prepared by PCR in an area of lowest homology to both CTE-I and MTE-I. Oligonucleotides were designed for PCR amplification of the mouse PPAR cDNA, based on the published sequence (25) (5'-TCTAGAGGGGACCTGAG AAACGCTG-3' and 5'-TCTAGAATTAGCCTCCGATCACCCC-3'), with the addition of XbaI restriction sites (indicated in bold). Reverse transcription for RT-PCR with mouse liver total RNA as a template was carried out using RT-PCR Kit (Amersham Pharmacia Biotech). PCR was performed in an Eppendorf Thermal cycler and the product obtained was cloned into the pcDNA3.1(+) expression vector (Invitrogen). Sequences were verified using the ABI Prism Dye Terminator Ready-Reaction Kit (Perkin-Elmer) and analysed at Cybergene AB (Huddinge, Sweden). Probes corresponding to ACOX and ß-actin were also used. All probes were labeled with -32P dCTP (NEN Life Science Products, Belgium) by random priming (Oligolabeling Kit, Amersham Pharmacia Biotech). RNA filters were pre-hybridized for 1 h in a solution containing 50 mM PIPES, 100 mM NaCl, 50 mM sodium dihydrogen phosphate, 1 mM EDTA, and 5% SDS at pH 6.8, together with 100 µg salmon sperm DNA (Sigma) at 65°C. After pre-hybridization, the filters were further hybridized overnight at 65°C with the relevant -32P-labeled probe. After hybridization, the filters were initially washed at 65°C in 1x SSC;5% SDS and further washed in decreasing concentrations of SSC-SDS solutions. Bands were visualized by exposure to X-ray film (CEA RP medical X-ray screen film) or phosphor imaging plates (Fujifilm). Signals were analyzed in a Fujifilm BAS-1800 using Image Gauge Software Version 3.0 or quantitated in an Image Master VDS (Amersham Pharmacia Biotech) using Image Master Program Version 3.0. Filters were stripped in boiling 0.5% SDS solution and re-probed as above.
Gel electrophoresis and Western blotting
Liver pieces from C57 BL/6 mice fasted for various time-points up to 24 h or treated with a 0.5% clofibrate-containing diet for 1 week were homogenized in 50 mM potassium phosphate buffer, pH 7.0 (0.1 g tissue in 200 µl buffer). Cytosolic fractions were prepared by centrifugation in an Eppendorf centrifuge at 15,000 g for 30 min at 4°C. Twenty-five micrograms total cytosolic protein was separated on a 10% sodium dodecylsulfate polyacrylamide gel (SDS-PAGE). Western blotting was performed by electrophoretic transfer of the separated proteins onto a nitrocellulose filter (Nitropure, Micron Separations Inc., Westborough, MA) using a Protean II xi cell (BioRad Laboratories, Hercules, CA). The blots were probed with an anti-MTE-I antibody previously described (11) and subsequently with horseradish peroxidase-conjugated secondary antibodies and visualized by enhanced chemiluminescence (ECLTM, Amersham Pharmacia Biotech) using X-ray film. Signals were analyzed using an Image Master VDS (Amersham Pharmacia Biotech) and Image Master Program Version 3.0.
Other methods
Acyl-CoA thioesterase activity and protein were measured essentially as described previously (26) (27).
 |
RESULTS |
|---|
CTE-I shows a diurnal regulation
The diurnal regulation of the cytosolic acyl-CoA thioesterase was investigated in C57 BL/6 mice over a 24-h period ( Fig 1). Mice were fed a normal chow diet and were killed every 4th h starting at 09.00 h. Quantitation of the mRNA signal for CTE-I, which shows a weak basal expression in liver, showed that during the light period (between 06.00 h and 18.00), when the animals were less active, levels of mRNA were increased, indicating an induction by fasting. During the dark period, when feeding takes place (between 18.00 h and 06.00), mRNA levels declined steadily, indicating a rapid nutritional regulation in response to refeeding.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1.
Diurnal variation of CTE-I mRNA expression in liver. Mice (C57 BL/6) were maintained on a normal chow diet ad libitum and were killed at the time-points indicated. The light period was between 06.00 and 18.00 and the dark period between 18.00 and 06.00. Total RNA was isolated from liver and Northern blot analysis was carried out on 20 µg RNA using an -32P-labeled full-length cDNA probe for CTE-I or a probe for ß-actin. Filters were exposed to X-ray film and signals were quantified using Image Master Software 3.0. The mean of CTE-I/actin mRNA ± range for two animals is shown.
|
|
Regulation of CTE-I by fat-free diet
Treatment of C57 BL/6 mice with a fat-free diet for 1 week was carried out and CTE-I mRNA expression in liver was repressed by more than half after 1 day and levels were less than 10% of basal level after 2 days of treatment ( Fig 2 A). The mRNA gradually increased again to about 25% of basal level by day 7 of treatment. The apparent down-regulation of CTE-I expression by treatment with a fat-free diet could not be correlated to changes in PPAR expression, which was found to be unchanged and likewise, expression of ACOX, an apparently strictly PPAR -regulated gene, was also unchanged by this treatment (Fig 2b). These data suggest that CTE-I expression is regulated in a PPAR -independent manner during treatment of mice with a fat-free diet.
Involvement of the PPAR in acyl-CoA thioesterase expression in liver
PPAR -null mice were used to examine whether the previously reported induction of CTE-I and MTE-I mRNA by fasting is mediated by the PPAR (13). Fasting induced both of these thioesterase transcripts in liver of wild-type animals ( Fig 3 A), with CTE-I mRNA induced at least 15-fold and MTE-I about 4-fold. Two further thioesterases recently cloned by us (15), peroxisomal acyl-CoA thioesterase Ia and Ib (PTE-Ia and PTE-Ib), showed a doubling of the mRNA transcript levels by fasting. However, an induction of CTE-I was still observed after fasting of PPAR -null mice, which was similar to the level of induction in wild-type animals. MTE-I mRNA levels were also induced by fasting in wild-type animals, with the PPAR -null mice showing a minor induction compared to control PPAR -null animals. In contrast, the induction of the peroxisomal thioesterases was PPAR -dependent during fasting, with no increase in mRNA evident in fasted PPAR -null mice. Acyl-CoA oxidase (ACOX), which is widely used as a marker enzyme of peroxisome proliferator-mediated gene expression, was induced several fold by fasting and this induction was also dependent on the PPAR .
The role of the PPAR in clofibrate-induced increases in CTE-I and MTE-I mRNA in mouse liver was also examined. Treatment for 1 week with clofibrate caused a substantial induction of both CTE-I and MTE-I mRNA in liver (Fig 3b), and this induction was not found in similarly treated PPAR -null mice, demonstrating that this clofibrate-mediated induction is completely PPAR -dependent in liver. Investigation of CTE-I/MTE-I protein levels in liver homogenates of clofibrate treated mice showed a 7.3-fold induction in wild-type mice after 1 week, whereas protein levels in PPAR -null animals were not increased by this treatment (Fig 3c). Notably, the constitutive expression of CTE-I/MTE-I in liver of PPAR -null mice is about 2-fold higher at the mRNA and protein levels (Fig 3a and Fig 3c) compared to wild-type animals, indicating an involvement of this receptor in the basal expression of CTE-I/MTE-I in liver.
Regulation of CTE-I by fasting
The dramatic increase in thioesterase mRNA levels by fasting, together with the fact that this induction is partially independent of the PPAR for CTE-I, was surprising and was further investigated. Male C57 BL/6 mice were fasted for 6, 12, 18, and 24 h and Western blot analysis showed that CTE-I protein level in cytosol was increased already after 6 h and peaked after 18 h fasting ( Fig 4). The increase in CTE-I was even more evident at the mRNA level (data not shown). Although CTE-I enzyme activity represents only a fraction of the total activity in cytosol in untreated mice, the activity in cytosol increased from 7.3 to 10.1 nmol/min x mg protein (about 38% increase) after 24 h fasting. Fasting induced a dramatic and rapid increase in hepatic CTE-I mRNA and protein levels, which suggested a sensitive regulation of this enzyme in response to nutritional changes. To examine the regulation of CTE-I mRNA levels after restoring access to food, mice were fasted for 24 h and then refed a normal chow diet for the time-points indicated ( Fig 5). The CTE-I cDNA probe hybridized to the CTE-I transcript of 1.8 kb and also to a second transcript of 2.6 kb, the latter which we have identified as MTE-I (15). Consistent with previous results, CTE-I mRNA levels were induced about 17-fold after mice were fasted for 24 h. However, within 3 h of replacement of the diet, the mRNA levels returned to almost control value. CTE-I mRNA levels continued to decline further to only 20% of original control values after 9 h of refeeding, with some slight increase in the RNA message visible after 30 h refeeding,

View larger version (18K):
[in this window]
[in a new window]
|
Figure 4.
Regulation of acyl-CoA thioesterase protein in liver by fasting. Groups of two animals (C57 BL/6) were fasted for the indicated times. Western blot analysis was carried out using 25 µg liver cytosolic protein from mice fasted for the time-points indicated. The filter was hybridized with an anti-MTE-I antibody as described in Materials and Methods (upper panel). The signal was quantified using Image Master Software 3.0 as shown in the lower panel (mean ± range of two animals at each time-point).
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Figure 5.
Regulation of CTE-I mRNA expression in liver by fasting and refeeding. Groups of two animals (C57 BL/6) were fasted for 24 h and then refed a normal chow diet for 3, 6, 9, 12, 24, and 30 h (H). Mice were killed and total RNA was isolated from liver. Northern blot analysis was carried out on 20 µg RNA using an -32P-labeled full-length cDNA probe for CTE-I or a probe for ß-actin as shown in the upper panel. The signals were quantified using Image Master Software 3.0 and the lower panel shows the fold induction of CTE-I mRNA as mean and range of two animals (C: control; F: fasting 24 h).
|
|
Involvement of the PPAR in regulation of acyl-CoA thioesterases in heart and other tissues by fasting
Determination of the expression of CTE-I and MTE-I mRNAs in tissues other than liver where ß-oxidation of fatty acids is important as an energy source (heart, kidney, and brown adipose tissue (BAT)) was investigated ( Fig 6 A). After 24 h fasting, CTE-I mRNA was increased in both heart and kidney, by about 10-fold and 3.4-fold respectively, while MTE-I was increased at least 2-fold in heart and 3.2-fold in kidney. CTE-I and MTE-I mRNAs in BAT were unchanged after this treatment. ACOX, an indicator of PPAR -dependent peroxisome proliferator-induced changes in gene expression, was also examined in these tissues. ACOX mRNA was 3-fold higher in heart and 1.6-fold higher in kidney after fasting. Quantitation of signals showed no apparent induction of this mRNA in BAT. Tissue-specific expression of PPAR was examined in various tissues of untreated mice (Fig 6b). The expression of PPAR was highest in BAT, liver, heart, kidney, and adrenal gland, and correlated well with the expression of CTE-I, MTE-I, and ACOX mRNAs in these tissues. Using the PPAR -null mice, the induction of CTE-I and MTE-I mRNAs in heart by fasting was further examined. In contrast to liver, the basal mRNA level for CTE-I and MTE-I was significantly lower in cardiac tissue of the PPAR -null mice compared to wild-type animals, suggesting that PPAR influences the basal expression of these genes also in heart (Fig 6c). Fasted wild-type animals showed at least a 10-fold induction of expression of CTE-I and a 2-fold induction of MTE-I after 24 h, consistent with previous results. However, CTE-I mRNA was 2.4-fold higher in fasted PPAR -null mice compared to control PPAR -null mice, but no significant increase in MTE-I mRNA levels was detected by this treatment compared to controls. CTE-I mRNA in heart from fasted PPAR -null mice was still 1.8-fold higher than in wild-type controls. These data suggest that the regulation of MTE-I in heart by fasting is mediated by the PPAR , while also factors other than the PPAR regulate CTE-I mRNA in heart during fasting.
 |
DISCUSSION |
|---|
We have examined the regulation of various members of the peroxisome proliferator-induced long-chain acyl-CoA thioesterase multi-gene family, with particular emphasis on the cytosolic and mitochondrial enzymes. As expected, the peroxisome proliferator-induced up-regulation was completely PPAR -dependent, identifying a significant involvement of the PPAR in modulating the expression of these genes at the transcriptional level. The PPAR has been shown to play a key role in controlling the expression of many enzymes involved in liver fatty acid metabolism (19) (20) (28). Recent reports by several groups have identified the PPAR as the mediator in the adaptive response to fasting (21) (22) (23). Using the PPAR -null mouse model, the up-regulation of many genes involved in fatty acid oxidation was shown to be PPAR -dependent during fasting, such as medium chain acyl-CoA dehydrogenase and ACOX (23) and the CYP4A genes (21). Interestingly two genes were identified that were highly induced in the fasted state, but this induction was not dependent on the PPAR signaling pathway, namely carnitine palmitoyltransferase I (CPT-I) and short chain acyl-CoA dehydrogenase (22) (23). Our findings show that the cytosolic thioesterase CTE-I is also induced in a PPAR -independent manner during fasting, suggesting that other signaling pathways may be activated in the fasting state that control the expression of some genes involved in lipid metabolism. This activation pathway may involve other lipid-activated nuclear receptors such as PPAR or ARP-1 or a yet unidentified fatty acid-activated receptor, which could be involved in regulating CTE-I at the basal level. PPAR is ubiquitously expressed and although a function for PPAR remains to be established, it can be activated by a similar set of ligands to PPAR , indicating that it may respond to similar endogenous signals (4). The induction of CTE-I during fasting could be explained by hormonal changes, such as an increase in glucocorticoids, but the activation of CTE-I by a lipid-activated receptor is supported by our data after treatment with a fat-free diet which caused a slow reduction in CTE-I mRNA expression (after 1 to 2 days), suggesting that a decrease in fatty acids rather than hormonal changes may be responsible for the reduced expression.
The in vivo functions for long-chain acyl-CoA thioesterases have not been elucidated, although it has been suggested that they may be involved in lipid metabolism by modulating cellular non-esterified fatty acids and acyl-CoA concentrations. Because several pathophysiological conditions like starvation, diabetes, and some other metabolic diseases are accompanied by elevated tissue levels of fatty acids, these fatty acids may have an important role in activating the PPAR and thereby increase the transcription of genes encoding lipid metabolizing enzymes. It has been demonstrated that fatty acids can activate the PPAR in reporter gene systems (24) and that fatty acids bind to the PPAR , and thus may act as the natural ligands for this receptor (4) (5). It was also recently reported that the muscle CPT-I gene is activated by fatty acids via the PPAR in cardiac myocytes (29). Thus, the hydrolysis of long-chain acyl-CoAs to free fatty acids and CoA by the cytosolic thioesterase CTE-I may provide free fatty acids as ligands for the PPAR . As CTE-I is rapidly induced during fasting (protein is increased already after 6 h), we hypothesize that in the fasted state, when levels of fatty acids and acyl-CoA esters in liver are high, CTE-I is rapidly induced in a PPAR -independent manner and could act by supplying ligand for this receptor. This will result in activation of PPAR -regulated genes, including CTE-I, which itself will be further up-regulated. This cycle of events may act as an amplifier of the PPAR signaling pathway. It is likely that a factor or enzyme involved in nutritional regulation of gene expression would be rapidly regulated and, in this respect, the increase in CTE-I mRNA by fasting is very rapidly repressed by refeeding, with mRNA levels decreased to less than 20% of control within 9 h.
It has been speculated that the CYP4A enzymes may have a regulatory role in control of hepatic concentrations of putative endogenous fatty acid activators of the PPAR . A recent report showed that hepatic CYP4A mRNA is induced in response to fasting and diabetes in rats and mice (21). Using PPAR -null mice, this response was shown to be mediated by the PPAR in mouse liver. However, the induction of CYP4A protein and activity levels required at least 24 h before detection, indicating that the induction of CYP4A activity is unlikely to be a prerequisite for PPAR activation and induction of PPAR -inducible enzymes.
Acyl-CoA thioesters have been implicated in regulation of gene transcription as it was recently demonstrated that various acyl-CoAs bind to the HNF-4 and could modulate the transcriptional activity in a fatty acyl-specific manner (3). Thus, it is possible that the cytosolic acyl-CoA thioesterase may be of importance in modulating the transcriptional activation via PPAR versus HNF-4 by affecting cellular free fatty acid and acyl-CoA levels. This modulation may be important especially under conditions of fasting when the levels of other proteins that interact with free fatty acids and acyl-CoAs, such as fatty acid binding protein (FABP) and acyl-CoA binding protein (ACBP), are not changed significantly. Studies on ACBP (which has been suggested to act as a "sink" for acyl-CoAs (30)), show that the mRNA level was reduced by 50% after mice were fasted for 24 h (31). The ACBP binds fatty acyl-CoAs with very high affinity, indicating that the free concentrations of acyl-CoA are very low in vivo. Liver FABP, on the other hand, binds free fatty acids with 3;4 orders of magnitude lower affinity (KD ~ 1 µM), suggesting that the concentrations of free fatty acids may be much higher during certain physiological conditions. Liver FABP shows a slow rate of turnover and the level is not acutely modulated by dietary or diurnal changes (32). Thus, it appears that neither ACBP nor liver FABP is regulated to any large extent during acute changes in nutritional status, suggesting that fasting may lead to a large increase in free fatty acid levels in the liver.
The expression of MTE-I is up-regulated by peroxisome proliferators in a PPAR -dependent mechanism, indicating that the gene may contain a functional PPRE. MTE-I is mainly expressed in heart, brown adipose tissue, kidney, and muscle and is strongly induced in liver, kidney, and heart by fasting or in liver and kidney after treatment of mice with peroxisome proliferators, which is consistent with a function in fatty acid degradation. The acyl-CoA chain-length specificity of the MTE-I enzyme is similar to the chain-length specificity of mitochondrial very long-chain acyl-CoA dehydrogenase (11). The similar acyl-CoA chain-length preference of MTE-I to the very long-chain acyl-CoA dehydrogenase may be interpreted as a possible role for MTE-I in the regulation of the relative amounts of acyl-CoA/acyl-carnitine/free fatty acids under various conditions where fatty acid load may differ significantly. Fatty acyl groups are transported into the mitochondria in the form of acylcarnitine via a translocase system. During conditions such as fasting, there is an increased dependence on ß-oxidation for energy supply. Fasting is associated with an increased uptake of acylcarnitine into the mitochondria, where the acyl group is transferred back to CoA, thus re-generating acyl-CoA for ß-oxidation. The latter reaction is catalyzed by carnitine palmitoyltransferase II (CPT-II). During conditions of high intramitochondrial acyl-CoA, this enzyme may catalyze the reverse reaction to generate acylcarnitine. Acylcarnitine is a much stronger surfactant than acyl-CoA or free fatty acids (33) and could cause membrane damage, therefore the hydrolysis of acyl-CoAs by MTE-I would prevent CPT-II catalyzing the back reaction to form acylcarnitine. Heterologously expressed rat liver CPT-II shows an estimated Km for palmitoyl-CoA of about 34 µM (34), whereas purified rat liver MTE-I shows a Km of 6 µM for palmitoyl-CoA (11), indicating that MTE-I, by hydrolysis of acyl-CoA, could prevent catalysis of the back reaction by CPT-II and thus may act in a protective manner to prevent formation of carnitine esters.
Recently, an enzyme involved in steroid synthesis, arachidonic acid-related thioesterase involved in steroidogenesis (ARTISt), was purified (35) and cloned (36). The sequence of this enzyme was found to be identical to the sequence of MTE-I, suggesting that the MTE-I protein may also have an important role in the adrenocorticotropin-stimulated mobilization of arachidonic acid, thus stimulating steroidogenesis in adrenal gland. Consistent with this is the finding of relatively strong expression of MTE-I in mouse adrenal gland (15).
Peroxisomal acyl-CoA thioesterase activity has been characterized in liver and brown adipose tissue and a long-chain acyl-CoA thioesterase activity (maximally active on myristoyl-CoA) was shown to be increased in liver peroxisomes after treatment of rats with peroxisome proliferators (10) (37). We recently cloned two peroxisomal acyl-CoA thioesterases that vary markedly in tissue expression (15). PTE-Ia is expressed in all tissues investigated in mice (liver, kidney, heart, brown adipose tissue, lung, brain, muscle, and adrenal gland), in line with the general tissue expression of peroxisomal ß-oxidation enzymes, and was inducible in liver by clofibrate and fasting. Thus, PTE-Ia may have a function in peroxisomes in maintaining long-chain acyl-CoA/CoA levels for optimal ß-oxidation. This is supported by a recent study demonstrating that disruption of a gene in S. cerevisiae (where fatty acid oxidation is exclusively a peroxisomal process) encoding a peroxisomal thioesterase, impaired growth on oleate (38) (39). Although thioesterase activity has not been considered important in peroxisomal ß-oxidation, it appears that intraperoxisomal CoA levels must be closely regulated for efficient ß-oxidation in this organelle.
PTE-Ib shows a very different tissue distribution with strong expression only in kidney and liver and weak expression in intestine, adrenal gland, and brown and white adipose tissue. The function of PTE-Ib may therefore be more restricted to regulating liver;kidney specific metabolic pathways, possibly being involved in regulating conjugation of bile acids to glycine and taurine. This activity is catalyzed by a bile acid;CoA:amino acid N-acyltransferase which is expressed in liver and kidney (40) (41) (42).
All four acyl-CoA thioesterase genes are highly regulated by peroxisome proliferators and by fasting, suggesting functions for these enzymes in lipid metabolism. The different subcellular localizations of these enzymes propose that they have different functions in vivo. It is therefore important to further characterize the regulation of these genes using cloned promoters and reporter gene systems and to investigate their activity towards various types of lipids such as straight chain acyl-CoAs, branched chain acyl-CoAs, 3-hydroxy acyl-CoAs, CoA esters of bile acid intermediates, etc. However, the findings that the nutritional regulation of CTE-I is very rapid and mainly PPAR -independent and that the enzyme is localized in the cytosol suggest a possible role for this enzyme in PPAR signaling. The definitive functions of these enzymes are likely to be revealed using gene targeting, which work is currently in progress.
 |
FOOTNOTES |
|---|
1 Present address: Astra Pain Control AB, Novum, Huddinge, Sweden. 
 |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Takashi Hashimoto (Shinshu University School of Medicine, Matsumoto, Japan) for the ACOX probe. This study was supported by grants from the Swedish Research Council for Engineering Sciences, the Swedish Natural Science Research Council, Pharmacia & Upjohn, the Swedish Medical Research Council, Magnus Bergvalls Stiftelse, Stiftelsen Sigurd and Elsa Goljes Minne and the Dublin Institute of Technology.
Manuscript received November 4, 1999; and in revised form February 3, 2000
Abbreviations:
CTE-I, cytosolic acyl-CoA thioesterase I; MTE-I, mitochondrial acyl-CoA thioesterase I; PTE-Ia and Ib, peroxisomal acyl-CoA thioesterase Ia and b; PPAR, peroxisome proliferator-activated receptor; PPRE, peroxisome proliferator response element; CoA, coenzyme A; ACOX, acyl-CoA oxidase; PCR, polymerase chain reaction; bp, base pairs; kb, kilo base pairs; PIPES, 1,4-piperazinediethanesulfonic acid; BAT, brown adipose tissue; SDS, sodium dodecylsulfate; ARP-1, apolipoprotein A-I regulatory protein I
 |
REFERENCES |
|---|
- Waku, K. 1992. Origins and fates of fatty acyl-CoA esters. Biochim. Biophys. Acta. 1124:101-111[Medline].
- Faergeman, N. J., Knudsen, J. 1997. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and cell signalling. Biochem. J. 323:1-12.
- Hertz, R., Magenheim, J., Berman, I., Bar-Tana, J. 1998. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4
. Nature. 392:512-516[Medline].
- Forman, B. M., Chen, J., Evans, R. M. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors
and . Proc. Natl. Acad. Sci. USA. 94:4312-4317[Abstract/Free Full Text].
- Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., Lehmann, J. M. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors
and . Proc. Natl. Acad. Sci. USA. 94:4318-4323[Abstract/Free Full Text].
- Miyazawa, S., Furuta, S., Hashimoto, T. 1981. Induction of a novel long-chain acyl-CoA hydrolase in rat liver by administration of peroxisome proliferators. Eur. J. Biochem. 117:425-430[Medline].
- Berge, R. K., Skrede, S., Farstad, M. 1981. Effects of clofibrate on the intracellular localization of palmitoyl-CoA hydrolase and palmitoyl-L-carnitine hydrolase in rat liver. FEBS Lett. 124:43-47[Medline].
- Svensson, L. T., Wilcke, M., Alexson, S. E. H. 1995. Peroxisome proliferators differentially regulate long-chain acyl-CoA thioesterases in rat liver. Eur. J. Biochem. 230:813-820[Medline].
- Berge, R. K., Flatmark, T., Osmundsen, H. 1984. Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Eur. J. Biochem. 141:637-644[Medline].
- Wilcke, M., Alexson, S. E. H. 1994. Characterization of acyl-CoA thioesterase activity in isolated rat liver peroxisomes. Partial purification and characterization of a long-chain acyl-CoA thioesterase. Eur. J. Biochem. 222:803-811[Medline].
- Svensson, L. T., Alexson, S. E. H., Hiltunen, J. K. 1995. Very long chain and long chain acyl-CoA thioesterases in rat liver mitochondria. Identification, purification, characterization, and induction by peroxisome proliferators. J. Biol. Chem. 270:12177-12183[Abstract/Free Full Text].
- Svensson, L. T., Engberg, S. T., Aoyama, T., Usuda, N., Alexson, S. E. H., Hashimoto, T. 1998. Molecular cloning and characterization of a mitochondrial peroxisome proliferator-induced acyl-CoA thioesterase from rat liver. Biochem. J. 329:601-608.
- Lindquist, P. J. G., Svensson, L. T., Alexson, S. E. H. 1998. Molecular cloning of the peroxisome proliferator-induced 46 kDa cytosolic acyl-CoA thioesterase from mouse liver. Eur. J. Biochem. 251:631-640[Medline].
- Yamada, J., Suga, K., Furihata, T., Kitihara, M., Watanabe, T., Hosokawa, M., Satoh, T., Suga, T. 1998. cDNA cloning and genomic organization of peroxisome proliferator-inducible long-chain acyl-CoA hydrolase from rat liver cytosol. Biochem. Biophys. Res. Commun. 248:608-612[Medline].
- Hunt, M. C., Nousiainen, S. E. B., Huttunen, M. K., Orii, K., Svensson, L. T., Alexson, S. E. H. 1999. Peroxisome proliferator-induced long chain acyl-CoA thioesterases comprise a highly conserved novel multi-gene family involved in lipid metabolism. J. Biol. Chem. 274:34317-34326[Abstract/Free Full Text].
- Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., Green, S. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl-CoA oxidase gene. EMBO J. 11:433-439[Medline].
- Zhang, B., Marcus, S. L., Sajjadi, F. G., Alvares, K., Reddy, J. K., Subramani, S., Rachubinski, R. A., Capone, J. P. 1992. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA. 89:7541-7545[Abstract/Free Full Text].
- Muerhoff, A. S., Griffin, K. J., Johnson, E. F. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267:19051-19053[Abstract/Free Full Text].
- Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., Gonzalez, F. J. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:3012-3022[Abstract/Free Full Text].
- Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., Gonzalez, F. J. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor
(PPAR ). J. Biol. Chem. 273:5678-5684[Abstract/Free Full Text].
- Kroetz, D. L., Yook, P., Costet, P., Bianchi, P., Pineau, Y. 1998. Peroxisome proliferator-activated receptor
controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 273:31581-31589[Abstract/Free Full Text].
- Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., Wahli, W. 1999. Peroxisome proliferator-activated receptor
mediates the adaptive response to fasting. J. Clin. Invest. 103:1489-1498[Medline].
- Leone, T. C., Weinheimer, C. J., Kelly, D. P. 1999. A critical role for the peroxisome proliferator-activated receptor
(PPAR ) in the cellular fasting response: The PPAR -null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA. 96:7473-7478[Abstract/Free Full Text].
- Göttlicher, M., Widmark, E., Li, Q., Gustafsson, J-Å. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 89:4653-4657[Abstract/Free Full Text].
- Issemann, I., Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:645-650[Medline].
- Alexson, S. E. H., Nedergaard, J. 1988. A novel type of short- and medium-chain acyl-CoA hydrolases in brown adipose tissue mitochondria. J. Biol. Chem. 263:13564-13571[Abstract/Free Full Text].
- Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein/dye binding. Anal. Biochem. 72:248-254[Medline].
- Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., Latruffe, N. 1998. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor
and activators in a tissue- and inducer-specific manner. J. Biol. Chem. 273:16710-16714[Abstract/Free Full Text].
- Brandt, J., Djouadi, F., Kelly, D. P. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor
. J. Biol. Chem. 273:23786-23792[Abstract/Free Full Text].
- Mandrup, S., Jepsen, R., Skøtt, H., Rosendal, J., Højrup, P., Kristiansen, K., Knudsen, J. 1993. Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. Biochem. J. 290:369-374.
- Sterchele, P. F., Vanden Heuvel, J. P., Davis, J. W., II, Shrago, E., Knudsen, J., Peterson, R. E. 1994. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perflurodecanoic acid in rats. Biochem. Pharmacol. 48:955-966[Medline].
- Bass, N. M., Manning, J. A., Ockner, R. K. 1985. Turnover and short-term regulation of fatty acid binding protein in liver. J. Biol. Chem. 260:9603-9607[Abstract/Free Full Text].
- Goni, F. M., Requero, M. A., Alonso, A. 1996. Palmitoylcarnitine, a surface-active metabolite. FEBS Lett. 390:1-5[Medline].
- Mann, W. R., Yan, B., Dragland, C. J., Bell, P. A. 1995. Kinetic, circular dichroism and fluorescence studies on heterologously expressed carnitine palmitoyltransferase II. J. Enzyme Inhib. 9:303-308[Medline].
- Paz, C., Dada, L. A., Cornejo Maciel, M. F., Mele, P. G., Cymeryng, C. B., Neuman, I., Mendez, C. F., Finkielstein, C. V., Solano, A. R., Park, M., Fischer, W. H., Towbin, H., Scartazzini, R., Podestá, E. J. 1994. Purification of a novel 43-kDa protein (p43) intermediary in the activation of steroidogenesis from rat adrenal gland. Eur. J. Biochem. 224:709-716[Medline].
- Finkielstein, C., Maloberti, P., Mendez, C. F., Paz, C., Cornejo Maciel, F., Cymeryng, C., Neuman, I., Dada, L., Mele, P. G., Solano, A., Podestá, E. J. 1998. An adrenocorticotropin-regulated phosphoprotein intermediary in steroid synthesis is similar to an acyl-CoA thioesterase enzyme. Eur. J. Biochem. 256:60-66[Medline].
- Alexson, S. E. H., Osmundsen, H., Berge, R. K. 1989. The presence of acyl-CoA hydrolase in rat brown-adipose-tissue peroxisomes. Biochem. J. 262:41-46[Medline].
- Geraghty, M. T., Bassett, D., Morrell, J. C., Gatto, G. J., Jr., Bai, J., Geisbrecht, B. V., Hieter, P., Gould, S. J. 1999. Detecting patterns of protein distribution and gene expression in silico. Proc. Natl. Acad. Sci. USA. 96:2937-2942[Abstract/Free Full Text].
- Jones, J. M., Nau, K., Geraghty, M. T., Erdmann, R., Gould, S. J. 1999. Identification of peroxisomal acyl-CoA thioesterases in yeast and human. J. Biol. Chem. 274:9216-9223[Abstract/Free Full Text].
- Kwakye, J. B., Johnson, M. R., Barnes, S., Grizzle, W. E., Diasio, R. B. 1991. Identification of bile acid CoA:amino acid N-acyltransferase in rat kidney. Biochem. J. 280:821-824.
- Falany, C. N., Johnson, M. R., Barnes, S., Diasio, R. B. 1994. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acetyltranferase. J. Biol. Chem. 269:19375-19379[Abstract/Free Full Text].
- Kase, B. F., Björkhem, I. 1988. Peroxisomal bile acid-CoA: amino-acid N-acyltransferase in rat liver. J. Biol. Chem. 264:9220-9223[Abstract/Free Full Text].

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. K. Westin, M. C. Hunt, and S. E. H. Alexson
Peroxisomes Contain a Specific Phytanoyl-CoA/Pristanoyl-CoA Thioesterase Acting as a Novel Auxiliary Enzyme in {alpha}- and beta-Oxidation of Methyl-branched Fatty Acids in Mouse
J. Biol. Chem.,
September 14, 2007;
282(37):
26707 - 26716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dongol, Y. Shah, I. Kim, F. J. Gonzalez, and M. C. Hunt
The acyl-CoA thioesterase I is regulated by PPAR{alpha} and HNF4{alpha} via a distal response element in the promoter
J. Lipid Res.,
August 1, 2007;
48(8):
1781 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Gerber, B. J. Aronow, and M. A. Matlib
Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1198 - C1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Dhahbi, T. Tsuchiya, H.-J. Kim, P. L. Mote, and S. R. Spindler
Gene Expression and Physiologic Responses of the Heart to the Initiation and Withdrawal of Caloric Restriction
J Gerontol A Biol Sci Med Sci,
March 1, 2006;
61(3):
218 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. K. Westin, M. C. Hunt, and S. E. H. Alexson
The Identification of a Succinyl-CoA Thioesterase Suggests a Novel Pathway for Succinate Production in Peroxisomes
J. Biol. Chem.,
November 18, 2005;
280(46):
38125 - 38132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Solaas, B. F. Kase, V. Pham, K. Bamberg, M. C. Hunt, and S. E. H. Alexson
Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR{alpha} activation favors the formation of unconjugated bile acids
J. Lipid Res.,
June 1, 2004;
45(6):
1051 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. K. Westin, S. E. H. Alexson, and M. C. Hunt
Molecular Cloning and Characterization of Two Mouse Peroxisome Proliferator-activated Receptor {alpha} (PPAR{alpha})-regulated Peroxisomal Acyl-CoA Thioesterases
J. Biol. Chem.,
May 21, 2004;
279(21):
21841 - 21848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Tilton, J. M. Shockey, and J. Browse
Biochemical and Molecular Characterization of ACH2, an Acyl-CoA Thioesterase from Arabidopsis thaliana
J. Biol. Chem.,
February 27, 2004;
279(9):
7487 - 7494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cabrero, M. Merlos, J. C. Laguna, and M. V. Carrera
Down-regulation of acyl-CoA oxidase gene expression and increased NF-{kappa}B activity in etomoxir-induced cardiac hypertrophy
J. Lipid Res.,
February 1, 2003;
44(2):
388 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Huhtinen, J. O'Byrne, P. J. G. Lindquist, J. A. Contreras, and S. E. H. Alexson
The Peroxisome Proliferator-induced Cytosolic Type I Acyl-CoA Thioesterase (CTE-I) Is a Serine-Histidine-Aspartic Acid alpha /beta Hydrolase
J. Biol. Chem.,
January 25, 2002;
277(5):
3424 - 3432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Hunt, Y.-Z. Yang, G. Eggertsen, C. M. Carneheim, M. Gafvels, C. Einarsson, and S. E. H. Alexson
The Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Regulates Bile Acid Biosynthesis
J. Biol. Chem.,
September 8, 2000;
275(37):
28947 - 28953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Hunt, K. Solaas, B. F. Kase, and S. E. H. Alexson
Characterization of an Acyl-CoA Thioesterase That Functions as a Major Regulator of Peroxisomal Lipid Metabolism
J. Biol. Chem.,
January 4, 2002;
277(2):
1128 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
Advertisement
Advertisement
|